StonvexLoading…
StonvexStonvexStonvexCore line items from CTSO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.86M | $37.06M | $27.83M | $18.34M |
Operating Income | $-3.04M | $-14.75M | $-10.36M | $-7.50M |
Net Income | $-5.13M | $-8.20M | $-2.70M | $469.00K |
EPS (Diluted) | $-0.08 | $-0.13 | $-0.04 | $0.01 |
Total Assets | $40.56M | $44.18M | $45.75M | $47.99M |
Total Liabilities | $38.37M | $38.28M | $36.73M | $36.40M |
Cash & Equivalents | $4.81M | $6.25M | $7.54M | $10.20M |
Free Cash Flow OCF − CapEx | $-1.17M | $-12.54M | $-7.61M | $-5.01M |
Shares Outstanding | 62.73M | 62.80M | 62.79M | 62.61M |